ROQUEFORT THERAPEUTICS PLC

Pre-Annual General Meeting Information • Nov 19, 2021

National Storage Mechanism | Additional information

RNS Number : 8893S

Roquefort Investments PLC

19 November 2021

19 November 2021

Roquefort Investments plc

("Roquefort Investments" or the "Company")

Circular and Notice of General Meeting

Roquefort Investments (LSE:ROQ), the London listed investment company established to acquire businesses focused on early-stage opportunities in the medical biotechnology sector, announces that a Circular including a Notice of General Meeting, is being posted to shareholders today.

The General Meeting will be held at the offices of Locke Lord (UK) LLP, 201 Bishopsgate, London EC2M 3AB at 10.00 a.m. on 13 December 2021.

The Circular and Form of Proxy is available on the Company's Website:

https://www.roquefortinvest.com/shareholder-documents

Enquiries:

Roquefort Investments plc
Stephen West (Chairman)	+44 (0)20 3290 9339
Optiva Securities Limited (Broker)
Christian Dennis	+44 (0)20 3411 1881

For further information, please visit www.roquefortinvest.com and @roquefortinvest on Twitter.

LEI: ‎254900P4SISIWOR9RH34

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NOGGPGWPGUPGGMR